{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:52:37Z","timestamp":1786981957606,"version":"build-2736575974"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Osteoporos"],"DOI":"10.1007\/s11657-025-01570-z","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T03:49:02Z","timestamp":1752637742000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Real-world data from a national survey on management of CKD-associated osteoporosis among Italian nephrologists"],"prefix":"10.1007","volume":"20","author":[{"given":"Maria","family":"Fusaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Althea","family":"Cossettini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia Vanessa","family":"Re Sart\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Aghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"Mereu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Gallieni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Cosmai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Bellasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo Maria","family":"Alfieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Cejka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"McCloskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Cavalier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas C.","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas L.","family":"Nickolas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Brandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Marino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Giannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Sella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano Paride","family":"Arcidiacono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Simioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Plebani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Zaninotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"De Nicola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmelita","family":"Marcantoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin H.","family":"de Borst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura","family":"Ravera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Frediani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Bover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Helene","family":"Lafage-Proust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Yves","family":"Reginster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bertoldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Tripepi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Haarhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"An initiative and on behalf of the CKD-MBD working group the European Renal Association and the Committee of Scientific Advisors and National Societies of the IOF","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,16]]},"reference":[{"issue":"4","key":"1570_CR1","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1007\/s00223-020-00777-1","volume":"108","author":"JB Cannata-And\u00eda","year":"2021","unstructured":"Cannata-And\u00eda JB et al (2021) Chronic kidney disease-mineral and bone disorders: pathogenesis and management. Calcif Tissue Int 108(4):410\u2013422. https:\/\/doi.org\/10.1007\/s00223-020-00777-1","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"1570_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/MNH.0000000000000467","volume":"28","author":"LD Quarles","year":"2019","unstructured":"Quarles LD (2019) Fibroblast growth factor 23 and \u03b1-Klotho co-dependent and independent functions. Curr Opin Nephrol Hypertens 28(1):16\u201325. https:\/\/doi.org\/10.1097\/MNH.0000000000000467","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"4","key":"1570_CR3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/1744-9987.12772","volume":"23","author":"M Mizobuchi","year":"2019","unstructured":"Mizobuchi M, Ogata H, Koiwa F (2019) Secondary hyperparathyroidism: pathogenesis and latest treatment. Ther Apher Dial 23(4):309\u2013318. https:\/\/doi.org\/10.1111\/1744-9987.12772","journal-title":"Ther Apher Dial"},{"issue":"3","key":"1570_CR4","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1053\/j.ajkd.2021.06.031","volume":"79","author":"C Ginsberg","year":"2022","unstructured":"Ginsberg C, Ix JH (2022) Diagnosis and management of osteoporosis in advanced kidney disease: a review\u201d, (in eng). Am J Kidney Dis 79(3):427\u2013436. https:\/\/doi.org\/10.1053\/j.ajkd.2021.06.031","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"1570_CR5","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/ki.2013.547","volume":"86","author":"KL Naylor","year":"2014","unstructured":"Naylor KL et al (2014) The three-year incidence of fracture in chronic kidney disease. Kidney Int 86(4):810\u2013818. https:\/\/doi.org\/10.1038\/ki.2013.547","journal-title":"Kidney Int"},{"issue":"11","key":"1570_CR6","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1515\/cclm-2014-0194","volume":"52","author":"M Fusaro","year":"2014","unstructured":"Fusaro M et al (2014) The relationship between the Spine Deformity Index, biochemical parameters of bone metabolism and vascular calcifications: results from the Epidemiological VERtebral FRACtures iTalian Study (EVERFRACT) in dialysis patients. Clin Chem Lab Med 52(11):1595\u20131603. https:\/\/doi.org\/10.1515\/cclm-2014-0194","journal-title":"Clin Chem Lab Med"},{"issue":"4","key":"1570_CR7","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1359\/jbmr.091025","volume":"25","author":"S Giannini","year":"2010","unstructured":"Giannini S et al (2010) Persistent secondary hyperparathyroidism and vertebral fractures in kidney transplantation: role of calcium-sensing receptor polymorphisms and vitamin D deficiency. J Bone Miner Res 25(4):841\u2013848. https:\/\/doi.org\/10.1359\/jbmr.091025","journal-title":"J Bone Miner Res"},{"issue":"10","key":"1570_CR8","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.3390\/nu14102124","volume":"14","author":"M Haarhaus","year":"2022","unstructured":"Haarhaus M et al (2022) Alkaline phosphatase: an old friend as treatment target for cardiovascular and mineral bone disorders in chronic kidney disease. Nutrients 14(10):2124. https:\/\/doi.org\/10.3390\/nu14102124","journal-title":"Nutrients"},{"issue":"5","key":"1570_CR9","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1681\/ASN.2017050584","volume":"29","author":"S Salam","year":"2018","unstructured":"Salam S, Gallagher O, Gossiel F, Paggiosi M, Khwaja A, Eastell R (2018) Diagnostic accuracy of biomarkers and imaging for bone turnover in renal osteodystrophy. J Am Soc Nephrol 29(5):1557\u20131565. https:\/\/doi.org\/10.1681\/ASN.2017050584","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"1570_CR10","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1053\/j.ajkd.2021.07.027","volume":"79","author":"HS J\u00f8rgensen","year":"2022","unstructured":"J\u00f8rgensen HS et al (2022) Diagnostic accuracy of noninvasive bone turnover markers in renal osteodystrophy. Am J Kidney Dis 79(5):667\u2013676.e1. https:\/\/doi.org\/10.1053\/j.ajkd.2021.07.027","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"1570_CR11","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1053\/j.ajkd.2015.02.323","volume":"66","author":"M Haarhaus","year":"2015","unstructured":"Haarhaus M, Monier-Faugere MC, Magnusson P, Malluche HH (2015) Bone alkaline phosphatase isoforms in hemodialysis patients with low versus non-low bone turnover: a diagnostic test study. Am J Kidney Dis 66(1):99\u2013105. https:\/\/doi.org\/10.1053\/j.ajkd.2015.02.323","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"1570_CR12","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.3390\/nu14091742","volume":"14","author":"M Fusaro","year":"2022","unstructured":"Fusaro M et al (2022) Time for revival of bone biopsy with histomorphometric analysis in chronic kidney disease (CKD): moving from skepticism to pragmatism. Nutrients 14(9):1742. https:\/\/doi.org\/10.3390\/nu14091742","journal-title":"Nutrients"},{"issue":"19","key":"1570_CR13","doi-asserted-by":"publisher","first-page":"4617","DOI":"10.3390\/jcm10194617","volume":"10","author":"L Dalle Carbonare","year":"2021","unstructured":"Dalle Carbonare L et al (2021) Bone biopsy for histomorphometry in chronic kidney disease (CKD): state-of-the-art and new perspectives. J Clin Med 10(19):4617. https:\/\/doi.org\/10.3390\/jcm10194617","journal-title":"J Clin Med"},{"key":"1570_CR14","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1038\/ki.2009.188","volume":"113","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group","year":"2009","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl 113:S1\u2013130. https:\/\/doi.org\/10.1038\/ki.2009.188","journal-title":"Kidney Int Suppl"},{"issue":"1","key":"1570_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","volume":"7","author":"DC Wheeler","year":"2017","unstructured":"Wheeler DC, Winkelmayer WC (2017) KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD) Kidney. Int Suppl 7(1):1\u201359. https:\/\/doi.org\/10.1016\/j.kisu.2017.04.001","journal-title":"Int Suppl"},{"key":"1570_CR16","doi-asserted-by":"publisher","first-page":"115689","DOI":"10.1016\/j.bone.2020.115689","volume":"142","author":"S Salam","year":"2021","unstructured":"Salam S, Gallagher O, Hughes D, Khwaja A, Eastell R (2021) The role of static bone histomorphometry in diagnosing renal osteodystrophy. Bone 142:115689. https:\/\/doi.org\/10.1016\/j.bone.2020.115689","journal-title":"Bone"},{"issue":"6","key":"1570_CR17","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1210\/jcem.81.6.8964862","volume":"81","author":"BL Clarke","year":"1996","unstructured":"Clarke BL et al (1996) \u201cChanges in quantitative bone histomorphometry in aging healthy men. J Clin Endocrinol Metab 81(6):2264\u20132270. https:\/\/doi.org\/10.1210\/jcem.81.6.8964862","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1570_CR18","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1093\/ndt\/gfw082","volume":"31","author":"DJ Goldsmith","year":"2016","unstructured":"Goldsmith DJ (2016) \u201cPro: should we correct vitamin D deficiency\/insufficiency in chronic kidney disease patients with inactive forms of vitamin D or just treat them with active vitamin D forms? Nephrol Dial Transplant 31(5):698\u2013705. https:\/\/doi.org\/10.1093\/ndt\/gfw082","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"1570_CR19","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.3390\/nu15071576","volume":"15","author":"J Bover","year":"2023","unstructured":"Bover J et al (2023) Vitamin D and chronic kidney disease association with mineral and bone disorder: an appraisal of tangled guidelines. Nutrients 15(7):1576. https:\/\/doi.org\/10.3390\/nu15071576","journal-title":"Nutrients"},{"issue":"2","key":"1570_CR20","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/MNH.0000000000000585","volume":"29","author":"MJ Damasiewicz","year":"2020","unstructured":"Damasiewicz MJ, Nickolas TL (2020) Bisphosphonate therapy in CKD: the current state of affairs. Curr Opin Nephrol Hypertens 29(2):221\u2013226. https:\/\/doi.org\/10.1097\/MNH.0000000000000585","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"12","key":"1570_CR21","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.3390\/nu14122369","volume":"14","author":"C Delli Poggi","year":"2022","unstructured":"Delli Poggi C, Fusaro M, Mereu MC, Brandi ML, Cianferotti L (2022) Cardiovascular safety and effectiveness of bisphosphonates: from intervention trials to real-life data. Nutrients 14(12):2369. https:\/\/doi.org\/10.3390\/nu14122369","journal-title":"Nutrients"},{"key":"1570_CR22","doi-asserted-by":"publisher","first-page":"204209861983813","DOI":"10.1177\/2042098619838138","volume":"10","author":"U Kirchmayer","year":"2019","unstructured":"Kirchmayer U et al (2019) \u201cBisphosphonates and cardiovascular risk in elderly patients with previous cardiovascular disease: a population-based nested case-control study in Italy\u201d, (in eng). Ther Adv Drug Saf 10:2042098619838138. https:\/\/doi.org\/10.1177\/2042098619838138","journal-title":"Ther Adv Drug Saf"},{"key":"1570_CR23","doi-asserted-by":"publisher","first-page":"269613","DOI":"10.1155\/2014\/269613","volume":"2014","author":"M Okamoto","year":"2014","unstructured":"Okamoto M, Yamanaka S, Yoshimoto W, Shigematsu T (2014) Alendronate as an effective treatment for bone loss and vascular calcification in kidney transplant recipients. J Transplant 2014:269613. https:\/\/doi.org\/10.1155\/2014\/269613","journal-title":"J Transplant"},{"issue":"3","key":"1570_CR24","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.nefro.2018.10.009","volume":"39","author":"J Bover","year":"2019","unstructured":"Bover J et al (2019) Osteoporosis, bone mineral density and CKD-MBD (II): therapeutic implications. Nefrologia 39(3):227\u2013242. https:\/\/doi.org\/10.1016\/j.nefro.2018.10.009","journal-title":"Nefrologia"},{"issue":"8","key":"1570_CR25","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1002\/jbmr.4563","volume":"37","author":"PD Miller","year":"2022","unstructured":"Miller PD et al (2022) Efficacy and safety of romosozumab among postmenopausal women with osteoporosis and mild-to-moderate chronic kidney disease. J Bone Miner Res 37(8):1437\u20131445. https:\/\/doi.org\/10.1002\/jbmr.4563","journal-title":"J Bone Miner Res"},{"issue":"6","key":"1570_CR26","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1007\/s00774-021-01253-y","volume":"39","author":"M Sato","year":"2021","unstructured":"Sato M, Inaba M, Yamada S, Emoto M, Ohno Y, Tsujimoto Y (2021) Efficacy of romosozumab in patients with osteoporosis on maintenance hemodialysis in Japan; an observational study. J Bone Miner Metab 39(6):1082\u20131090. https:\/\/doi.org\/10.1007\/s00774-021-01253-y","journal-title":"J Bone Miner Metab"},{"issue":"5","key":"1570_CR27","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1093\/jbmr\/zjae062","volume":"39","author":"HS J\u00f8rgensen","year":"2024","unstructured":"J\u00f8rgensen HS, Moe S, Nickolas TL (2024) Diagnosis and therapeutic decisions of osteoporosis in chronic kidney disease. J Bone Miner Res 39(5):531\u2013535. https:\/\/doi.org\/10.1093\/jbmr\/zjae062","journal-title":"J Bone Miner Res"},{"issue":"1","key":"1570_CR28","doi-asserted-by":"publisher","first-page":"sfad290","DOI":"10.1093\/ckj\/sfad290","volume":"17","author":"M Fusaro","year":"2024","unstructured":"Fusaro M et al (2024) Real-world usage of chronic kidney disease - mineral bone disorder (CKD-MBD) biomarkers in nephrology practices. Clin Kidney J 17(1):sfad290. https:\/\/doi.org\/10.1093\/ckj\/sfad290","journal-title":"Clin Kidney J"},{"issue":"6","key":"1570_CR29","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/sj.ki.5002769","volume":"73","author":"FC Barreto","year":"2008","unstructured":"Barreto FC (2008) K\/DOQI-recommended intact PTH levels do not prevent low-turnover bone disease in hemodialysis patients. Kidney Int 73(6):771\u2013777. https:\/\/doi.org\/10.1038\/sj.ki.5002769","journal-title":"Kidney Int"},{"issue":"1","key":"1570_CR30","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.kint.2017.04.006","volume":"92","author":"M Ketteler","year":"2017","unstructured":"Ketteler M et al (2017) Executive summary of the 2017 KDIGO chronic kidney disease-mineral and bone disorder (CKD-MBD) guideline update: what\u2019s changed and why it matters. Kidney Int 92(1):26\u201336. https:\/\/doi.org\/10.1016\/j.kint.2017.04.006","journal-title":"Kidney Int"},{"issue":"12","key":"1570_CR31","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1002\/jbmr.4440","volume":"36","author":"M Fusaro","year":"2021","unstructured":"Fusaro M et al (2021) Oral calcitriol use, vertebral fractures, and vitamin K in hemodialysis patients: a cross-sectional study. J Bone Miner Res 36(12):2361\u20132370. https:\/\/doi.org\/10.1002\/jbmr.4440","journal-title":"J Bone Miner Res"},{"issue":"1","key":"1570_CR32","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11657-020-0702-2","volume":"15","author":"SM Titan","year":"2020","unstructured":"Titan SM et al (2020,) Bisphosphonate utilization across the spectrum of eGFR. Arch Osteoporos 15(1):69. https:\/\/doi.org\/10.1007\/s11657-020-0702-2","journal-title":"Arch Osteoporos"},{"issue":"4","key":"1570_CR33","first-page":"510","volume":"21","author":"R Bergner","year":"2008","unstructured":"Bergner R, Henrich D, Hoffmann M, Schmidt-Gayk H, Lenz T, Upperkamp M (2008) Treatment of reduced bone density with ibandronate in dialysis patients. J Nephrol 21(4):510\u2013516","journal-title":"J Nephrol"},{"key":"1570_CR34","doi-asserted-by":"publisher","first-page":"S88","DOI":"10.1046\/j.1523-1755.63.s85.21.x","volume":"85","author":"JV Torregrosa","year":"2003","unstructured":"Torregrosa JV, Moreno A, Mas M, Ybarra J, Fuster D (2003) Usefulness of pamidronate in severe secondary hyperparathyroidism in patients undergoing hemodialysis. Kidney Int Suppl 85:S88\u201390. https:\/\/doi.org\/10.1046\/j.1523-1755.63.s85.21.x","journal-title":"Kidney Int Suppl"},{"issue":"4","key":"1570_CR35","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/j.1440-1797.2005.00436.x","volume":"10","author":"JB Wetmore","year":"2005","unstructured":"Wetmore JB, Benet LZ, Kleinstuck D, Frassetto L (2005) Effects of short-term alendronate on bone mineral density in haemodialysis patients. Nephrology (Carlton) 10(4):393\u2013399. https:\/\/doi.org\/10.1111\/j.1440-1797.2005.00436.x","journal-title":"Nephrology (Carlton)"},{"issue":"7","key":"1570_CR36","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1177\/10815589231184215","volume":"71","author":"Y Leng","year":"2023","unstructured":"Leng Y, Yu X, Yang Y, Xia Y (2023) Efficacy and safety of medications for osteoporosis in kidney transplant recipients or patients with chronic kidney disease: a meta-analysis. J Investig Med 71(7):760\u2013772. https:\/\/doi.org\/10.1177\/10815589231184215","journal-title":"J Investig Med"},{"issue":"1","key":"1570_CR37","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11657-020-00746-z","volume":"15","author":"MS Ali","year":"2020","unstructured":"Ali MS et al (2020) Alendronate use and bone mineral density gains in women with moderate-severe (stages 3B\u20135) chronic kidney disease: an open cohort multivariable and propensity score analysis from Funen, Denmark. Arch Osteoporos 15(1):81. https:\/\/doi.org\/10.1007\/s11657-020-00746-z","journal-title":"Arch Osteoporos"},{"issue":"5","key":"1570_CR38","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1002\/jbmr.4235","volume":"36","author":"DE Robinson","year":"2021","unstructured":"Robinson DE et al (2021) Safety of oral bisphosphonates in moderate-to-severe chronic kidney disease: a binational cohort analysis. J Bone Miner Res 36(5):820\u2013832. https:\/\/doi.org\/10.1002\/jbmr.4235","journal-title":"J Bone Miner Res"},{"issue":"3","key":"1570_CR39","doi-asserted-by":"publisher","first-page":"92335","DOI":"10.5500\/wjt.v14.i3.92335","volume":"14","author":"GA Georgopoulou","year":"2024","unstructured":"Georgopoulou GA, Papasotiriou M, Ntrinias T, Savvidaki E, Goumenos DS, Papachristou E (2024) Impact of bisphosphonate treatment on bone mineral density after kidney transplant. World J Transplant 14(3):92335","journal-title":"World J Transplant"},{"issue":"2","key":"1570_CR40","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1210\/clinem\/dgaa851","volume":"106","author":"A Broadwell","year":"2021","unstructured":"Broadwell A et al (2021) Denosumab safety and efficacy among participants in the FREEDOM extension study with mild to moderate chronic kidney disease. J Clin Endocrinol Metab 106(2):397\u2013409. https:\/\/doi.org\/10.1210\/clinem\/dgaa851","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1570_CR41","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1038\/s41598-020-59143-8","volume":"10","author":"K Kunizawa","year":"2020","unstructured":"Kunizawa K et al (2020) Denosumab for dialysis patients with osteoporosis: a cohort study. Sci Rep 10(1):2496. https:\/\/doi.org\/10.1038\/s41598-020-59143-8","journal-title":"Sci Rep"},{"issue":"6","key":"1570_CR42","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1001\/jama.2023.28239","volume":"331","author":"ST Bird","year":"2024","unstructured":"Bird ST et al (2024) Severe hypocalcemia with denosumab among older female dialysis-dependent patients. JAMA 331(6):491\u2013499. https:\/\/doi.org\/10.1001\/jama.2023.28239","journal-title":"JAMA"},{"issue":"1","key":"1570_CR43","doi-asserted-by":"publisher","first-page":"7781","DOI":"10.1038\/s41598-022-12029-3","volume":"12","author":"M Hori","year":"2022","unstructured":"Hori M et al (2022) Effects of bone turnover status on the efficacy and safety of denosumab among haemodialysis patients. Sci Rep 12(1):7781. https:\/\/doi.org\/10.1038\/s41598-022-12029-3","journal-title":"Sci Rep"},{"issue":"6","key":"1570_CR44","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1001\/jama.2023.24072","volume":"331","author":"P Khairallah","year":"2024","unstructured":"Khairallah P, Nickolas TL (2024) Managing osteoporosis in dialysis-a medical catch-22. JAMA 331(6):477\u2013479. https:\/\/doi.org\/10.1001\/jama.2023.24072","journal-title":"JAMA"},{"issue":"3","key":"1570_CR45","doi-asserted-by":"publisher","first-page":"sfae048","DOI":"10.1093\/ckj\/sfae048","volume":"17","author":"MJ Lloret","year":"2024","unstructured":"Lloret MJ, J\u00f8rgensen HS, Evenepoel P (2024) Denosumab-induced hypocalcemia in patients treated with dialysis: an avoidable complication? Clin Kidney J 17(3):sfae048. https:\/\/doi.org\/10.1093\/ckj\/sfae048","journal-title":"Clin Kidney J"},{"issue":"2","key":"1570_CR46","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.bone.2008.04.007","volume":"43","author":"PD Miller","year":"2008","unstructured":"Miller PD et al (2008) Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: a randomized blinded phase 2 clinical trial. Bone 43(2):222\u2013229. https:\/\/doi.org\/10.1016\/j.bone.2008.04.007","journal-title":"Bone"},{"issue":"4","key":"1570_CR47","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1210\/jc.2010-1502","volume":"96","author":"HG Bone","year":"2011","unstructured":"Bone HG et al (2011) Effects of denosumab treatment and discontinuation on bone mineral density and bone turnover markers in postmenopausal women with low bone mass. J Clin Endocrinol Metab 96(4):972\u2013980. https:\/\/doi.org\/10.1210\/jc.2010-1502","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"1570_CR48","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.2215\/CJN.0000000000000213","volume":"18","author":"K Iseri","year":"2023","unstructured":"Iseri K et al (2023) Long-term effect of denosumab on bone disease in patients with CKD. Clin J Am Soc Nephrol 18(9):1195\u20131203. https:\/\/doi.org\/10.2215\/CJN.0000000000000213","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"1570_CR49","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1007\/s00198-015-3234-7","volume":"26","author":"S Papapoulos","year":"2015","unstructured":"Papapoulos S et al (2015) The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study. Osteoporos Int 26(12):2773\u20132783. https:\/\/doi.org\/10.1007\/s00198-015-3234-7","journal-title":"Osteoporos Int"},{"issue":"4","key":"1570_CR50","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1007\/s00198-015-3377-6","volume":"27","author":"K Sumida","year":"2016","unstructured":"Sumida K et al (2016) Once-weekly teriparatide in hemodialysis patients with hypoparathyroidism and low bone mass: a prospective study. Osteoporos Int 27(4):1441\u20131450. https:\/\/doi.org\/10.1007\/s00198-015-3377-6","journal-title":"Osteoporos Int"},{"issue":"3","key":"1570_CR51","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1159\/000316708","volume":"33","author":"D Cejka","year":"2010","unstructured":"Cejka D, Kodras K, Bader T, Haas M (2010) \u201cTreatment of hemodialysis-associated adynamic bone disease with teriparatide (PTH1-34): a pilot study. Kidney Blood Press Res 33(3):221\u2013226. https:\/\/doi.org\/10.1159\/000316708","journal-title":"Kidney Blood Press Res"},{"issue":"3","key":"1570_CR52","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.bone.2010.05.022","volume":"47","author":"A Miyauchi","year":"2010","unstructured":"Miyauchi A, Matsumoto T, Sugimoto T, Tsujimoto M, Warner MR, Nakamura T (2010) Effects of teriparatide on bone mineral density and bone turnover markers in Japanese subjects with osteoporosis at high risk of fracture in a 24-month clinical study: 12-month, randomized, placebo-controlled, double-blind and 12-month open-label phases. Bone 47(3):493\u2013502. https:\/\/doi.org\/10.1016\/j.bone.2010.05.022","journal-title":"Bone"},{"issue":"3","key":"1570_CR53","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.kint.2021.04.043","volume":"100","author":"M Haarhaus","year":"2021","unstructured":"Haarhaus M, Evenepoel P, European Renal Osteodystrophy (EUROD) workgroup; Chronic Kidney Disease Mineral and Bone Disorder (CKD-MBD) working group of the European Renal Association\u2013European Dialysis and Transplant Association (ERA-EDTA) (2021) Differentiating the causes of adynamic bone in advanced chronic kidney disease informs osteoporosis treatment. Kidney Int 100(3):546\u2013558. https:\/\/doi.org\/10.1016\/j.kint.2021.04.043","journal-title":"Kidney Int"}],"container-title":["Archives of Osteoporosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-025-01570-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11657-025-01570-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-025-01570-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T21:16:56Z","timestamp":1766524616000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11657-025-01570-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,16]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1570"],"URL":"https:\/\/doi.org\/10.1007\/s11657-025-01570-z","relation":{},"ISSN":["1862-3514"],"issn-type":[{"value":"1862-3514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,16]]},"assertion":[{"value":"23 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Maria Fusaro, Althea Cossettini, Giulia Vanessa Re Sart\u00f2, Andrea Aghi, Maria Cristina Mereu, Maurizio Gallieni, Laura Cosmai, Antonio Bellasi, Carlo Alfieri, Daniel Cejka, Eugene Mc Closkey, Etienne Cavalier, Nicholas C. Harvey, Thomas L. Nickolas, Maria Luisa Brandi, Serge Ferrari, Carmela Marino, Sandro Giannini, Stefania Sella, Gaetano Paride Arcidiacono, Paolo Simioni, Mario Plebani, Martina Zaninotto, Luca De Nicola, Carmelita Marcantoni, Martin H De Borst, Maura Ravera, Bruno Frediani, Jordi Bover, Marie-Helene Lafage-Proust, Jean-Yves Reginster, Francesco Bertoldo, Giovanni Tripepi and Mathias Haarhaus declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"96"}}